Gosset Cholesterol side-chain cleavage enzyme Overview
Cholesterol side-chain cleavage enzyme (P450scc) is a mitochondrial enzyme responsible for catalyzing the conversion of cholesterol to pregnenolone, marking the initial and rate-limiting step in steroid hormone biosynthesis in steroidogenic tissues. It belongs to the cytochrome P450 superfamily and is encoded by the CYP11A1 gene. P450scc is localized in the inner mitochondrial membrane of the adrenal cortex, ovaries, testis, and placenta. Genetic deficiencies or mutations in CYP11A1 result in severe disorders of steroidogenesis, including adrenal insufficiency and congenital lipoid adrenal hyperplasia, and play a critical role in the production of glucocorticoids, mineralocorticoids, and sex steroids. Drugs such as aminoglutethimide, ketoconazole, and mitotane can inhibit P450scc, resulting in decreased steroid hormone output.
Mechanism of Action
Inhibition of cholesterol side-chain cleavage enzyme activity (blocks conversion of cholesterol to pregnenolone, inhibits steroid hormone synthesis)
Biological Functions
Disease Associations
Safety Considerations
- Suppressing P450scc may cause adrenal insufficiency or steroid hormone deficiency
- Over-inhibition may impair sexual development and stress response
Interacting Drugs
Associated Biomarkers
| Biomarker |
|---|
| CYP11A1 gene mutations (for congenital adrenal insufficiency and lipoid CAH) |
| Reduced pregnenolone levels |